Industry / Namibia
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Namibia Tightens Controls On Ephedrine-Containing Medicines
July 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Namibia is to follow South Africa's lead by rescheduling a number of medicines containing ephedrine, pseudoephedrine and d-norpseudoephedrine as prescription-only drugs. The new schedule will come into effect by the end of 2008. Neighbouring South Africa reclassified medicines containing ephedrine or its derivatives at the end of April